ArticleIn vivo (Athens, Greece)
Impact of ADC Value on Conversion Surgery for Unresectable Colorectal Liver Metastasis.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimWe examined the impact of apparent diffusion coefficients (ADC) calculated from diffusion-weighted-magnetic resonance imaging on prognostic prediction and establishment of a treatment strategy for conversion surgery in patients with initially unresectable colorectal liver metastasis (CRLM). PATIENTS AND
methodsThirty patients underwent conversion surgery for initially unresectable CRLM. The minimum ADC was calculated after chemotherapy. Patients were divided into low ADC (n=6) and high ADC (n=24) groups, and clinicopathological factors were compared between the two groups.
resultsThe low ADC group had higher rates of male sex, large tumor diameter and high carbohydrate antigen 19-9 level (≥37 U/ml) than the high ADC group (
conclusionADC values after chemotherapy can be used to estimate the prognosis after conversion hepatectomy for patients with initially unresectable CRLM. ADC values may therefore be helpful for selecting patients for conversion surgery after completing a FOLFOXIRI regimen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.